Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1722 (Tenapanor) Phase 1 study in healthy Japanese and Caucasian subjects
NCT02176252Phase 1Completed
- Sponsor
- Ardelyx
- Start
- Jul 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of tenapanor in irritable bowel syndrome (IBS) and hyperphosphatemia, sponsored by Ardelyx. Started Jul 2013; status: completed.
02
Drugs
tenapanor
03
Conditions
irritable bowel syndrome (IBS)hyperphosphatemia
Beyond the preview
Go deeper on NCT02176252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176252.